Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodayPrecious Metals
Gold Price TodayNew
Silver Price TodayNew
Platinum Price TodayNewSmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Fortis Healthcare
Large Cap•12,237 Employees•IPO 2007
Current Price
₹788.75
-6.25 (-0.79%)Updated
Today's Range
766.8
₹788.75
791
52 Week Range
52W Low₹595.80
52W High₹1104.30
₹788.75
Downside32.39%
Upside40.01%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹68,448.28 Cr
Market Cap
Total market value of companyP/E Ratio
68.17
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
7.76
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹13.43
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
5.51%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
12.00%
ROCE
Return on Capital Employed. >15% is goodNet Margin
12.02%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
67.97%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
10.93%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
16.60%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
51.30%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.28
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹118.11
Book Value
Net asset value per shareDividend Yield
0.12%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
31.20%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
4 points- •Fortis Healthcare reported a robust 51.3% increase in quarterly profit, demonstrating strong operational efficiency and profitability. This is supported by a healthy operating profit margin of 21.5%.
- •The company shows consistent quarterly sales growth of 16.6%, indicating strong market demand and effective business expansion, which contributes to overall revenue stability and future prospects.
Weaknesses
4 points- •Fortis Healthcare's Price-to-Earnings (PE) ratio of 86.40 is significantly higher than the sector PE of 73.28, suggesting the stock might be overvalued compared to its industry peers.
- •The company's Return on Capital Employed (ROCE) at 12.00% and Return on Equity (ROE) at 10.10% are relatively lower than some key peers, indicating less efficient capital utilization.
Opportunities
3 points- •As a key player in the 'Hospital' industry within the 'Healthcare' sector, Fortis is well-positioned to capitalize on increasing healthcare expenditure and demand for quality medical services.
- •The company's consistent quarterly sales growth of 16.6% and profit growth of 51.3% suggest strong underlying demand, offering potential for further market share expansion.
Threats
4 points- •The 'Hospital' industry is highly competitive, with strong peers like Apollo Hospitals and Max Healthcare, posing a significant threat to Fortis's market share and pricing power.
- •Fortis's high PE ratio of 86.40, significantly above the sector average, exposes it to valuation risk if future earnings growth does not meet the market's elevated expectations.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹845.97 | +₹57.22 | +7.25% |
| R3 | ₹821.77 | +₹33.02 | +4.19% |
| R2 | ₹806.38 | +₹17.63 | +2.24% |
| R1 | ₹797.57 | +₹8.82 | +1.12% |
| PIVOT | ₹782.18 | -6.57 | -0.83% |
| CURRENT | ₹788.75 | - | - |
| S1 | ₹724.97 | -₹63.78 | -8.09% |
| S2 | ₹749.17 | -₹39.58 | -5.02% |
| S3 | ₹757.98 | -₹30.77 | -3.90% |
| S4 | ₹773.37 | -₹15.38 | -1.95% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume-32.6% vs avg
1.17M
(02 Apr 2026)Delivery %-17.0% vs avg
40.5%
(02 Apr 2026)Avg Volume (20D)20-day average
1.74M
(04 Mar - 02 Apr)Avg Delivery %Trend ↓
57.5%
(04 Mar - 02 Apr)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Apollo Hospitals Enterprise Ltd
1.09L ₹ Cr
Best Profit Growth
Dr Agarwals Health Care Ltd
151.00 %
Highest Dividend Yield
Rainbow Childrens Medicare Ltd
0.51 %
Peer Comparison
| Company Name |
|---|
 Dr Agarwals Health Care Ltd |
 Apollo Hospitals Enterprise Ltd |
 Aster DM Healthcare Ltd |
 Healthcare Global Enterprises Ltd |
 Jupiter Life Line Hospitals Ltd |
 |
 Krishna Institute of Medical Sciences Ltd |
 Max Healthcare Institute Ltd |
 Global Health Ltd |
 Narayana Hrudayalaya Ltd |
 Rainbow Childrens Medicare Ltd |
About
Fortis Healthcare Ltd
Fortis Healthcare Limited is a major integrated healthcare provider in India, focusing on delivering a comprehensive range of secondary, tertiary, and quaternary care services. This means they handle a wide spectrum of medical needs, from routine care to highly specialized and complex treatments.
The breadth of their medical offerings is extensive, covering a vast array of specialties. This includes, but is not limited to, cardiology, oncology, neurology, orthopedics, gastroenterology, and various other surgical and medical disciplines. They also provide services in areas like cosmetology, dermatology, and mental health, demonstrating a commitment to a holistic approach to patient care.
Fortis operates across multiple healthcare verticals, ensuring a diversified and integrated healthcare delivery system. Their core business includes a network of hospitals, offering inpatient and outpatient services. In addition to hospitals, they also operate diagnostic centers and specialized day-care facilities, providing convenient access to a range of tests and procedures.
The company’s business model is centered around providing high-quality healthcare services across a wide range of specialties. Their presence in multiple healthcare verticals allows for a cohesive and comprehensive approach to patient care, from initial diagnosis and treatment to specialized procedures and ongoing support. This integrated approach aims to deliver a seamless and efficient healthcare experience.
Established in 1995 and headquartered in Gurugram, India, Fortis Healthcare Limited has a significant presence within the Indian healthcare market. Their wide range of services and multi-vertical approach positions them as a key player in the country's healthcare landscape.
COMPANY FACTS - FORTIS
Registered Address
Escorts Heart Institute And, Research Centre,, Okhla Road
New Delhi
DELHI
IN
Tel: 919205010100
Website:https://www.fortishealthcare.com/
Investor Relations:http://www.fortishealthcare.com/investors
Company Details
Group: Health Care Equipment & Services
Sector: Health Care
Industry: Health Care Providers & Services
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 12,237
IPO Date: 09/05/2007
MANAGEMENT - FORTIS
Mr. Leo Puri
Additional Independent Non-Executive Chairman of the Board
Dr. Ashutosh Raghuvanshi
Chief Executive Officer, Managing Director, Executive Director
Dr. Prem Nair
Non-Executive Vice Chairman of the Board
Mr. Vivek Goyal
Chief Financial Officer
Mr. Satyendra Chauhan
Compliance Officer, Company Secretary
Mr. Mehmet Ali Aydinlar
Non-Executive Director
Mr. Dilip Kadambi
Non-Executive Director
Mr. Tsin-Lin Lim
Non-Executive Director
Mr. Tomo Nagahiro
Non-Executive Director
Mr. Ashok Pandit
Non Executive Director
Mr. Indrajit Banerjee
Non-Executive Independent Director
Ms. Suvalaxmi Chakraborty
Non-Executive Independent Director
Investor Questions Answered
Fortis Healthcare Ltd (FORTIS) Stock FAQs
Get answers to the most common questions about Fortis Healthcare Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Fortis Healthcare Ltd (FORTIS) is ₹788.75. Today, the stock has declined by ₹6.25 (0.79%), trading in a range of ₹766.8 to ₹791. The stock opened at ₹790.05 with a trading volume of 11,71,512 shares.
Fortis Healthcare Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹68,448.28 crores, P/E ratio of 68.17, ROE of 5.51%, and ROCE of 12.00%. The dividend yield stands at 0.12%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Fortis Healthcare Ltd (FORTIS) is ₹1,104.3, while the 52-week low is ₹595.8. Currently trading at ₹788.75, the stock is 37.9% away from its 52-week low and 28.6% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Fortis Healthcare Ltd stock at ₹788.75 depends on multiple factors. The stock is currently trading with a P/E ratio of 68.17 and P/B ratio of N/A. Today's performance shows a loss of 0.79%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Fortis Healthcare Ltd offers a dividend yield of 0.12%, which means for every ₹100 invested at the current price of ₹788.75, you can expect to receive approximately ₹0.12 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Fortis Healthcare Ltd's key financial metrics include: P/E Ratio: 68.17, P/B Ratio: N/A, ROE: 5.51%, ROCE: 12.00%, Dividend Yield: 0.12%, EPS: ₹13.43, Book Value: ₹118.11, Debt-to-Equity: 0.28, and Current Ratio: N/A. The company's market cap stands at ₹68,448.28 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Fortis Healthcare Ltd stock opened at ₹790.05 and is currently trading at ₹788.75, showing a decline of ₹6.25 (0.79%). The intraday high is ₹791 and low is ₹766.8. The trading volume stands at 11,71,512 shares, indicating strong market participation today.
Fortis Healthcare Ltd has a Price-to-Earnings (P/E) ratio of 68.17, which means investors are willing to pay ₹68.17 for every ₹1 of earnings. With an EPS of ₹13.43, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Fortis Healthcare Ltd has a market capitalization of ₹68,448.28 crores, making it a mid-cap company. Market cap is calculated by multiplying the current stock price (₹788.75) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Fortis Healthcare Ltd has a book value of ₹118.11 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹788.75, which is 567.8% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Fortis Healthcare Ltd has a Return on Equity (ROE) of 5.51% and Return on Capital Employed (ROCE) of 12.00%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Fortis Healthcare Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Fortis Healthcare Ltd has a debt-to-equity ratio of 0.28, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Fortis Healthcare Ltd has an Earnings Per Share (EPS) of ₹13.43, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹788.75 and P/E ratio of 68.17, investors are paying 68.17 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Fortis Healthcare Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Fortis Healthcare Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Fortis Healthcare Ltd stock, consider: 1) Fundamental Analysis - Review P/E (68.17), ROE (5.51%), debt-to-equity (0.28), and growth rates. 2) Technical Analysis - Check 52-week range (₹595.80 - ₹1104.30), moving averages, and chart patterns. 3) Valuation - Compare current price (₹788.75) with book value (₹118.11) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Fortis Healthcare Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹788.75 is 7788x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Fortis Healthcare Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹595.80 - ₹1104.30). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.28 indicates leverage. 4) Liquidity Risk - Based on trading volume of 11,71,512 shares. 5) Valuation Risk - P/E of 68.17 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Fortis Healthcare Ltd operates in the industry with key metrics: P/E ratio of 68.17, ROE of 5.51%, market cap of ₹68,448.28 crores, and dividend yield of 0.12%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.28), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Fortis Healthcare Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹788.75, with a 52-week range of ₹595.80 to ₹1104.30. Based on fundamentals like P/E (68.17), ROE (5.51%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Fortis Healthcare Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹788.75. 2) Fundamental Deterioration - Declining ROE (currently 5.51%), increasing debt (D/E: 0.28), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Fortis Healthcare Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.12%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu